Jafron Biomedical Co.,Ltd. Statistics

Total Valuation

Jafron Biomedical Co.,Ltd. has a market cap or net worth of CNY 24.23 billion. The enterprise value is 23.14 billion.

Market Cap	24.23B
Enterprise Value	23.14B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 31, 2024

Share Statistics

Jafron Biomedical Co.,Ltd. has 774.36 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class	n/a
Shares Outstanding	774.36M
Shares Change (YoY)	-0.51%
Shares Change (QoQ)	+1.62%
Owned by Insiders (%)	51.44%
Owned by Institutions (%)	11.40%
Float	365.43M

Valuation Ratios

The trailing PE ratio is 30.91 and the forward PE ratio is 22.30. Jafron Biomedical Co.,Ltd.'s PEG ratio is 0.46.

PE Ratio	30.91
Forward PE	22.30
PS Ratio	9.44
PB Ratio	7.37
P/TBV Ratio	n/a
P/FCF Ratio	27.77
P/OCF Ratio	n/a
PEG Ratio	0.46

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.22, with an EV/FCF ratio of 26.52.

EV / Earnings	28.76
EV / Sales	8.79
EV / EBITDA	22.22
EV / EBIT	24.78
EV / FCF	26.52

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.49.

Current Ratio	3.77
Quick Ratio	3.36
Debt / Equity	0.49
Debt / EBITDA	1.55
Debt / FCF	1.85
Interest Coverage	15.06

Financial Efficiency

Return on equity (ROE) is 24.75% and return on invested capital (ROIC) is 11.94%.

Return on Equity (ROE)	24.75%
Return on Assets (ROA)	10.53%
Return on Capital (ROIC)	11.94%
Revenue Per Employee	1.09M
Profits Per Employee	334,083
Employee Count	2,408
Asset Turnover	0.47
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.81% in the last 52 weeks. The beta is 0.33, so Jafron Biomedical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+34.81%
50-Day Moving Average	29.39
200-Day Moving Average	25.89
Relative Strength Index (RSI)	48.61
Average Volume (20 Days)	10,246,490

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jafron Biomedical Co.,Ltd. had revenue of CNY 2.63 billion and earned 804.47 million in profits. Earnings per share was 1.01.

Revenue	2.63B
Gross Profit	2.12B
Operating Income	933.73M
Pretax Income	976.75M
Net Income	804.47M
EBITDA	1.04B
EBIT	933.73M
Earnings Per Share (EPS)	1.01

Full Income Statement

Balance Sheet

The company has 2.71 billion in cash and 1.62 billion in debt, giving a net cash position of 1.10 billion or 1.42 per share.

Cash & Cash Equivalents	2.71B
Total Debt	1.62B
Net Cash	1.10B
Net Cash Per Share	1.42
Equity (Book Value)	3.29B
Book Value Per Share	4.25
Working Capital	2.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.20 billion and capital expenditures -325.77 million, giving a free cash flow of 872.54 million.

Operating Cash Flow	1.20B
Capital Expenditures	-325.77M
Free Cash Flow	872.54M
FCF Per Share	1.13

Full Cash Flow Statement

Margins

Gross margin is 80.68%, with operating and profit margins of 35.48% and 30.56%.

Gross Margin	80.68%
Operating Margin	35.48%
Pretax Margin	37.11%
Profit Margin	30.56%
EBITDA Margin	39.39%
EBIT Margin	35.48%
FCF Margin	33.15%

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.23%.

Dividend Per Share	0.40
Dividend Yield	1.23%
Dividend Growth (YoY)	-40.30%
Years of Dividend Growth	n/a
Payout Ratio	42.08%
Buyback Yield	0.51%
Shareholder Yield	1.74%
Earnings Yield	3.24%
FCF Yield	3.60%

Dividend Details

Stock Splits

The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.

Last Split Date	May 20, 2020
Split Type	Forward
Split Ratio	1.9

Scores

Jafron Biomedical Co.,Ltd. has an Altman Z-Score of 7.21.

Altman Z-Score	7.21
Piotroski F-Score	n/a